49 Trascription factor TEAD4 is not required for bovine blastocyst formation

2022 ◽  
Vol 34 (2) ◽  
pp. 259
Author(s):  
A. Pérez-Gómez ◽  
L. González-Brusi ◽  
I. Muniesa-Martínez ◽  
P. García-Sacristán ◽  
P. Ramos-Ibeas ◽  
...  
2007 ◽  
Vol 7 (1) ◽  
pp. 64 ◽  
Author(s):  
Karen Goossens ◽  
Ann Van Soom ◽  
Mario Van Poucke ◽  
Leen Vandaele ◽  
Jo Vandesompele ◽  
...  

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Bradford W. Daigneault ◽  
Sandeep Rajput ◽  
George W. Smith ◽  
Pablo J. Ross

2021 ◽  
Vol 33 (2) ◽  
pp. 156
Author(s):  
A. C. Quiroga ◽  
C. de Frutos ◽  
E. Zurita ◽  
P. Bermejo-Álvarez

Prostaglandins (PGs) are lipid signalling molecules that play critical roles in gestation by promoting corpus luteus maintenance or luteolysis, and have been suggested to play other roles in early pregnancy, including embryo–maternal crosstalk. The signalling roles of PGs and other lipids are often mediated by peroxisome proliferator-activated receptors (PPARs), transcription factors that regulate the expression of other genes through PPAR-responsive elements. PPARG is a PPAR expressed by bovine pre-implantation embryos whose inhibition by morpholino intrauterine infusion has been reported to impair embryo development. As this approach causes PPARG depletion in both conceptus and uterus, it is unknown whether PPARG-mediated signalling in the embryo is required for embryo development. The objective of this study was to determine whether PPARG is required for blastocyst formation. For that aim, we have evaluated embryo development in PPARG knockout (KO) bovine embryos generated by CRISPR-Cas9 technology. Invitro matured oocytes were allocated in two groups: one was injected with mRNA encoding for Cas9 and sgRNA against PPARG to generate KO embryos (C+G, n=191) and the other was injected with mRNA alone (C, n=148), serving as a microinjection control generating only wild-type embryos. Following fertilization, embryos were allowed to develop to Day 8 blastocysts invitro. No differences were found in cleavage and blastocyst rates between both groups (cleavage 78.5±3.4 vs. 78.4±4.2; Day 7 blastocyst 17.3±3.9 vs. 10.8±2.9; Day 8 blastocyst 20.4±6.2 vs. 16.9±4.7; C+G vs. C; mean±s.e.m.; ANOVA P>0.05). Blastocysts of the C+G group were genotyped by clonal sequencing to determine which embryos in the C+G group were KO (i.e. harboured only frame-disrupting, KO alleles). Twenty-eight out of the 32 blastocysts analysed were edited (87.5%), of which 6 (18.8%) were KO. These results show that PPARG is not required for blastocyst formation, because KO embryos develop to that stage, but do not rule out a possible role in further developmental stages.


2010 ◽  
Vol 22 (2) ◽  
pp. 395 ◽  
Author(s):  
Karen Goossens ◽  
Dawit Tesfaye ◽  
Franca Rings ◽  
Karl Schellander ◽  
Michael Hölker ◽  
...  

The expression of the cytoskeleton protein Keratin 18 (KRT18) starts at the onset of bovine blastocyst formation. KRT18 is solely expressed in the trophectoderm and can therefore be used as a marker for trophectodermal differentiation. In the present study, the expression of KRT18 was suppressed by RNA interference to probe its functional importance in bovine blastocyst formation. Microinjection of KRT18 double-stranded RNA into the cytoplasm of zygotes resulted in reduced KRT18 mRNA (76% reduction) and protein expression at the blastocyst stage and a lower developmental competence (41% reduction in the percentage of blastocyst formation) compared with non-injected and phosphate-buffered saline (PBS)-injected controls. KRT18 downregulation was associated with reduced mRNA expression of KRT8, the binding partner of KRT18, but had no effect on the expression of KRT19, CDH1 and DSP, other genes involved in intermediate filament and cytoskeleton formation. The results of the present study demonstrated that KRT18 knockdown in preimplantation embryos results in reduced blastocyst formation, but no further morphological aberrations were observed with regard to the biological function of KRT18. These observations could be due to the function of KRT18 being replaced by that of another gene, the surviving blastocysts expressing the minimum level of KRT18 required for normal blastocyst development or the possibility that further aberrations may occur later in development.


Sign in / Sign up

Export Citation Format

Share Document